Journal of Commercial Biotechnology logo Palgrave Macmillan logo

Publisher: Palgrave Macmillan

Volume 9, Number 4, 1 June 2003
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial: Yin, yang and the biopharmaceutical industry
pp. 283-285(3)
Author: Miller, Henry I

Opinion piece: Biotechnology's growth-innovation paradox and the new model for success
pp. 286-288(3)
Author: Baker, Ann

Life after Enron and ImClone: Special concerns for the biotechnology company
pp. 289-296(8)
Author: Aronson, Neil H

The key to successful collaborations: Rigorous and independent due diligence
pp. 297-304(8)
Authors: Rhodes, Ian; Nelson, Craig; Berman, Gregory

Dominating global intellectual property: Overview of patentability in the USA, Europe and Japan
pp. 305-331(27)
Authors: Kowalski, Thomas J; Maschio, Antonio; Megerditchian, Samuel H

Patent issues and future trends in drug development
pp. 332-338(7)
Authors: Kermani, Faiz; Bonacossa, Pietro

Strategies for building a global healthcare biotechnology company
pp. 339-344(6)
Author: Geraghty, James A

Regulatory Submissions Trends Survey 2002
pp. 345-357(13)
Author: Semple, Ellen

Marketspace: Trends in biotherapeutics
pp. 358-363(6)
Author: Pavlou, Alex K

Legal and regulatory update: Voluntary withdrawal of marketing authorisations and consequences for parallel importers
pp. 364-371(8)
Author: Wilkinson, John

EU Financial accounts reports
pp. 372-374(3)
Author: Citron, David

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A